Drugmakers Comment on 340B Pricing and Monetary Penalty Proposed Rule

by Admin | September 16, 2015 9:58 am

September 16, 2015—The two major associations of brand-name drugmakers have issues with a proposed 340B program rule setting standards for calculating ceiling prices and implementing civil monetary penalties for drugmakers that knowingly and intentionally overcharge for 340B drugs.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2015/09/drugmakers-comment-on-340b-pricing-and-monetary-penalty-proposed-rule/

Copyright ©2026 340binformed.org unless otherwise noted.